Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 7,356 shares at $86.75 ($638K) on 2026-03-09, disclosed to the SEC on 2026-03-11.
Seasonal sale ($638k) by CHIEF EXECUTIVE OFFICER — this insider has traded WGS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.75 | 3,678 | $319K | 50.0% |
| 2 | $86.75 | 3,678 | $319K | 50.0% |
| Total | $86.75 avg | 7,356 | $638K | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |